PSMD1 and COVID-19: The quantification of S1‐specific antibody levels confirmed these results, showing that they had S1‐specific antibody levels below 200 BAU/ml (Table 1) which were lower than those of the majority (i.e., eight out of ten) of COVID‐19 convalescent subjects (Table 1).